These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Endothelin receptor blockade prevents the rise in pulmonary vascular resistance after cardiopulmonary bypass in lambs with increased pulmonary blood flow. Petrossian E; Parry AJ; Reddy VM; Akkersdijk GP; McMullan DM; Thompson L; Hendricks-Munoz KD; Hallak H; Hanley FL; Fineman JR J Thorac Cardiovasc Surg; 1999 Feb; 117(2):314-23. PubMed ID: 9918974 [TBL] [Abstract][Full Text] [Related]
45. [The changes of plasma endothelin concentration and its clinical significance in pulmonary hypertension associated with congenital heart defects]. Zhang S; Qi S; Shen X; Zhou S; Jin S Hunan Yi Ke Da Xue Xue Bao; 1997; 22(5):425-7. PubMed ID: 10073026 [TBL] [Abstract][Full Text] [Related]
46. Effects of pulsatile perfusion on plasma catecholamine levels and hemodynamics during and after cardiac operations with cardiopulmonary bypass. Minami K; Körner MM; Vyska K; Kleesiek K; Knobl H; Körfer R J Thorac Cardiovasc Surg; 1990 Jan; 99(1):82-91. PubMed ID: 2294367 [TBL] [Abstract][Full Text] [Related]
47. Acute-phase responses to cardiopulmonary bypass in children weighing less than 10 kilograms. Butler J; Pathi VL; Paton RD; Logan RW; MacArthur KJ; Jamieson MP; Pollock JC Ann Thorac Surg; 1996 Aug; 62(2):538-42. PubMed ID: 8694619 [TBL] [Abstract][Full Text] [Related]
48. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1. Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785 [TBL] [Abstract][Full Text] [Related]
49. [Effectiveness of continuous pulmonary perfusion during total cardiopulmonary bypass to prevent lung reperfusion injury]. Suzuki T; Fukuda T; Inoue Y; Aki A; Cho Y Nihon Kyobu Geka Gakkai Zasshi; 1997 Jan; 45(1):31-6. PubMed ID: 9028120 [TBL] [Abstract][Full Text] [Related]
50. The clinical value and risks of lung biopsy in children with congenital heart disease. Wilson NJ; Seear MD; Taylor GP; LeBlanc JG; Sandor GG J Thorac Cardiovasc Surg; 1990 Mar; 99(3):460-8. PubMed ID: 2106601 [TBL] [Abstract][Full Text] [Related]
51. [The effects of thyroid hormones and interleukin-8 levels on prognosis after congenital heart surgery]. Baysal A; Saşmazel A; Yıldırım Aİ; Koçak T; Sunar H; Zeybek R Turk Kardiyol Dern Ars; 2010 Dec; 38(8):537-43. PubMed ID: 21248453 [TBL] [Abstract][Full Text] [Related]
52. Cerebral vascular reactivity to carbon dioxide before and after cardiopulmonary bypass in children with congenital heart disease. Kawaguchi M; Ohsumi H; Ohnishi Y; Nakajima T; Kuro M J Thorac Cardiovasc Surg; 1993 Nov; 106(5):823-7. PubMed ID: 8231203 [TBL] [Abstract][Full Text] [Related]
53. Time course of endothelin-1 and nitrate anion levels after cardiopulmonary bypass in congenital heart defects. Hiramatsu T; Imai Y; Takanashi Y; Hoshino S; Yashima M; Tanaka SA; Chang D; Nakazawa M Ann Thorac Surg; 1997 Mar; 63(3):648-52. PubMed ID: 9066378 [TBL] [Abstract][Full Text] [Related]
54. The dynamic change of plasma endothelin-1 during the perioperative period in patients with rheumatic valvular disease and secondary pulmonary hypertension. Zhu ZG; Wang MS; Jiang ZB; Jiang Z; Xu SX; Ren CY; Shi MX J Thorac Cardiovasc Surg; 1994 Nov; 108(5):960-8. PubMed ID: 7967681 [TBL] [Abstract][Full Text] [Related]
55. Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity. Allen SW; Chatfield BA; Koppenhafer SA; Schaffer MS; Wolfe RR; Abman SH Am Rev Respir Dis; 1993 Aug; 148(2):519-22. PubMed ID: 8342919 [TBL] [Abstract][Full Text] [Related]
56. [Study on the effect of adrenomedulin and urotensin-II on pulmonary hypertension of patients with congenital heart disease]. Wang T; Li SX; Zhang XQ; Gu XH; Song Y; Zhang G; Wu SM Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(38):2691-5. PubMed ID: 16324296 [TBL] [Abstract][Full Text] [Related]
57. Transcoronary and pulmonary vascular dynamics of endothelin-1 in heart transplant recipients. Sudhir K; DeMarco T; Kumar S; Maganti K; Amidon TM; de Groot CJ; Klinski C; Lau D; Keith F; Taylor RN J Heart Lung Transplant; 1995; 14(2):230-5. PubMed ID: 7779840 [TBL] [Abstract][Full Text] [Related]
58. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Yoshibayashi M; Nishioka K; Nakao K; Saito Y; Matsumura M; Ueda T; Temma S; Shirakami G; Imura H; Mikawa H Circulation; 1991 Dec; 84(6):2280-5. PubMed ID: 1959183 [TBL] [Abstract][Full Text] [Related]
59. Post-cardiopulmonary bypass pulmonary hypertension in lambs with increased pulmonary blood flow. A role for endothelin 1. Reddy VM; Hendricks-Munoz KD; Rajasinghe HA; Petrossian E; Hanley FL; Fineman JR Circulation; 1997 Feb; 95(4):1054-61. PubMed ID: 9054770 [TBL] [Abstract][Full Text] [Related]
60. Complement and the damaging effects of cardiopulmonary bypass. Kirklin JK; Westaby S; Blackstone EH; Kirklin JW; Chenoweth DE; Pacifico AD J Thorac Cardiovasc Surg; 1983 Dec; 86(6):845-57. PubMed ID: 6606084 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]